TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/4/25 19:23 | 7/30/25 | CYCC | Cyclacel Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Lazar David E. | R1 | T | S | -83 | 12.36 | 0 | -7 | -4 | 156 | D | |||||||||||||||
2/28/25 16:48 | 2/26/25 | CYCC | Cyclacel Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Lazar David E. | R1 | OT | Interim | S.d | -5,508 | 0.0283 | 0 | -194,629 | -100 | 0 | D | ||||||||||||||
11/25/24 16:45 | 11/21/24 | LQR | Lqr House Inc. | NV | FdBev | Bev | Beverages | Lazar David E. | R1 | DO | P | S.m | 0 | 0.00 | 0 | -1,102 | -100 | 0 | D | ||||||||||||||
6/28/23 16:14 | 6/21/23 | TTNP | Titan Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Lazar David E. | C0 | DOT | CEO | S.a | -4,610 | 1.23 | 0 | -3,748 | -100 | 0 | M | ||||||||||||||
6/23/23 16:07 | 6/21/23 | TTNP | Titan Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Lazar David E. | C0 | DOT | CEO | S | -4,610 | 1.23 | 0 | -3,748 | -100 | 0 | M |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |